Clinical trial
Sulindac in Preventing Lung Cancer in Current or Former Smokers With Bronchial…
NCT00368927 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00368927 |
|---|---|
| Title | Sulindac in Preventing Lung Cancer in Current or Former Smokers With Bronchial Dysplasia |
| Official title | Randomized, Phase IIb Trial of Sulindac in Smokers With Bronchial Dysplasia |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Precancerous Condition, Stage I Non-small Cell Lung Cancer, Tobacco Use Disorder |
| Intervention type | Drug, Other |
| Interventions | sulindac, placebo |
| Enrollment | 61 |
| Start date | Aug 1, 2006 |
| Primary completion | May 1, 2010 |
| Completion | Dec 1, 2010 |
| First posted | Aug 29, 2006 |
| Last update posted | May 23, 2014 |
| Countries | Canada, United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: